Luminus Management LLC Evaxion Biotech A/S Transaction History

Luminus Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.07 $679,243 - $1.3 Million	-424,527 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.66 - $4.65 $940,211 - $1.64 Million	-353,463 Reduced 45.43%	424,527 $1.29 Million
Q4 2021 Feb 15, 2022	BUY	$4.0 - $12.68 $3.11 Million - $9.86 Million	777,990 New	777,990 $3.44 Million
Q2 2021 Aug 16, 2021	SELL	$5.2 - $7.94 $1.01 Million - $1.55 Million	-194,929 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.3 - $9.95 $1.03 Million - $1.94 Million	194,929 New	194,929 $1.15 Million

37.5K

Ticker EVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,977,900
Market Cap $35.7M
Description
Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

Stay updated on Luminus Management LLC with notifications on news.